"The compounding of knowledge leads to the compounding of wealth."
Shashank Mahajan
Founder, Value Educator
Browse by section
All articlesPharma Stocks in India: Research and Analysis
India is one of the largest suppliers of generic medicines in the world. Its listed pharma companies sell branded medicines through doctors in India and emerging markets, generics in the US and Europe, store-brand medicines for pharmacy chains, drug ingredients (APIs) and contract manufacturing (CDMO) for global drug companies.
Our pharma research follows each company from its own filings: what it sells and where, how regulators have rated its plants, its latest results and margins, and the risks to its plans. The table below links every pharma company we have covered.
See all 13 companies and articles we have covered ↓
Glenmark: The USD 700 Mn Cancer Deal and Its Brands
Pharma Stocks in India 2026: Generics, APIs and CDMOs
Granules India: From Paracetamol to a 65% Gross Margin
Natco Pharma: After Revlimid, 29 Patent Challenges
Shilpa Medicare: Cancer APIs, Films and Biosimilars
Alembic Pharma: US Plants Pay Back, Margin Hits 22.2%
All companies and articles in this section
13 research articles, A to Z.
Modern Warfare to Multibaggers
Key Trends. Strategic Shifts. Opportunities Ahead.
Don't Miss This Exclusive Webinar!
Join Value Educator to decode the key trends shaping India's defence sector and learn how to identify tomorrow's potential leaders in the space.
- In-depth research on India's defence sector
- Live Q&A session
- Actionable takeaways for long-term investors
